In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

Thirteen strains of Chlamydia pneumoniae were evaluated for their in vitro susceptibilities to azithromycin, clarithromycin, erythromycin, and tetracycline. The MIC ranges were 0.125 to 0.5 μg/ml for azithromycin, 0.031 to 1.0 μg/ml for clarithromycin, 0.125 to 1.0 μg/ml for erythromycin, and 0.125 to 1.0 μg/ml for tetracycline. The ranges for the minimal lethal concentrations were 0.125 to 0.5 μg/ml for azithromycin, 0.031 to 1.0 μg/ml for clarithromycin, 0.125 to 1.0 μg/ml for erythromycin, and 0.25 to 1.0 μg/ml for tetracycline. Clarithromycin and azithromycin were the most active antibiotics against C. pneumoniae in vitro.

Original languageEnglish (US)
Pages (from-to)212-214
Number of pages3
JournalAntimicrobial agents and chemotherapy
Volume40
Issue number1
DOIs
StatePublished - Jan 1996

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae'. Together they form a unique fingerprint.

Cite this